FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...